Last edition
News about Industrial talks
Indian Pharma's Turning Point: Can the Generics Giant Become a Global Innovator?
India’s pharma industry, long known as the “pharmacy of the world,” now aims to become an innovation hub. To understand this transition, Pharma Industrial India spoke to experts on moving beyond generics toward becoming an “innovator of the world.”
Industrial talks | 14/04/2026 | By Akanki | 367
Ofichem Group Unifies Global Brands Under Single Identity to Streamline Pharma Partnerships
Ofichem consolidates its global brands under one identity to deliver integrated pharmaceutical development and supply solutions.
Industrial talks | 11/04/2026 | By News Bureau | 214
TAE Life Sciences’ latest research demonstrates the potential of next-generation BNCT to combine targeted radiation with immune activation for improved cancer treatment outcomes.
Industrial talks | 11/04/2026 | By News Bureau | 108
Domestic Momentum Fails to Offset US Pressure on Pharma Margins: Report
India’s pharmaceutical sector is expected to report steady domestic growth in Q4 FY26, but overall earnings are likely to come under pressure due to continued weakness in the US market, according to a report by Nuvama Institutional Equities.
Industrial talks | 10/04/2026 | By Darshana | 160
OPPI Partners with NIPER-Raebareli to Boost Pharma Research and Scholar Support
The collaboration between OPPI and NIPER-Raebareli will provide research scholarships, industry mentorship and academic support to strengthen innovation and bridge the gap between pharmaceutical research and real-world healthcare needs.
Industrial talks | 09/04/2026 | By News Bureau | 137
Soleno Withdraws EU Filing for Rare Disease Drug Ahead of Neurocrine Takeover
Soleno Therapeutics has withdrawn its European marketing application for Vykat XR, a treatment for hyperphagia associated with Prader-Willi syndrome, ahead of its planned acquisition by Neurocrine Biosciences.
Industrial talks | 09/04/2026 | By Darshana | 146
IDF President-Elect meets Dr. Jitendra Singh to boost indigenous biosimilar insulin production and diabetes biomanufacturing in India, focusing on affordability, supply security, and industry collaboration.
Industrial talks | 08/04/2026 | By News Bureau | 106
Cipla USA Secures USFDA Approval for Generic Nintedanib to Treat Pulmonary Fibrosis
Cipla USA receives USFDA approval for generic Nintedanib capsules, expanding access to treatment for patients with idiopathic pulmonary fibrosis in the United States.
Industrial talks | 06/04/2026 | By News Bureau | 345
India Pharma 2026 to Spotlight Innovation-Driven Growth in Life Sciences
The Department of Pharmaceuticals (DoP), in collaboration with Federation of Indian Chambers of Commerce & Industry (FICCI) and Indian Pharmaceutical Alliance, will host the 9th edition of India Pharma 2026 on April 13–14, 2026, at Federation House, New Delhi.
Industrial talks | 06/04/2026 | By Darshana | 396
NICE Recommends Weekly Semaglutide Injection to Prevent Heart Attacks and Strokes
NICE advises use of semaglutide injections for patients with prior cardiovascular conditions and excess weight to lower risk of future serious events.
Industrial talks | 04/04/2026 | By News Bureau | 159
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy